Schleswig-Holstein

EQS-News: Cureus in Q3 2023: eight projects with 671 units completed, three properties sold, land acquisition continues

Retrieved on: 
Tuesday, October 17, 2023

Cureus in Q3 2023: eight projects with 671 units completed, three properties sold, land acquisition continues

Key Points: 
  • Cureus in Q3 2023: eight projects with 671 units completed, three properties sold, land acquisition continues
    The issuer is solely responsible for the content of this announcement.
  • Cureus in Q3 2023: eight projects with 671 units completed, three properties sold, land acquisition continues
    Cureus continues to purchase project properties, focus on North Rhine-Westphalia, Hesse, Lower Saxony, Schleswig-Holstein
    Hamburg, 9 October 2023.
  • ( Details here in the acquisition profile... )
    The portfolio now comprises 63 leased properties with 6,206 care places, 735 assisted living units and 25 other units.
  • Cureus currently has 1,817 care places, 181 assisted living units and 77 other units under construction in 20 projects.

Temtokibart achieves First Subject First Treatment (FSFT) milestone in Phase 2b trial

Retrieved on: 
Wednesday, October 11, 2023

LEO Pharma A/S, a global leader in medical dermatology, has today announced the First Subject First Treatment (FSFT) milestone for the Phase 2b clinical trial for temtokibart, LEO Pharma's IL-22RA1 antibody.2 The first patient dose was successfully administered on the 4th of October at the DermEdge Research Center in Ontario, Canada.

Key Points: 
  • LEO Pharma A/S, a global leader in medical dermatology, has today announced the First Subject First Treatment (FSFT) milestone for the Phase 2b clinical trial for temtokibart, LEO Pharma's IL-22RA1 antibody.2 The first patient dose was successfully administered on the 4th of October at the DermEdge Research Center in Ontario, Canada.
  • Temtokibart is an investigational monoclonal antibody currently in Phase 2 development for the treatment of moderate-to-severe atopic dermatitis (AD).
  • “By targeting the IL-22 pathway, this trial could provide additional insights into the pathophysiology of atopic dermatitis.”
    The Phase 2b trial will be overseen by a specialist steering committee, the purpose of which is to provide critical scientific guidance, oversee trial conduct and drive trial results, analysis and scientific communications.
  • LEO Pharma obtained the license to temtokibart in 2022 and now assumes the responsibility to develop and commercialize the drug for inflammatory skin disorders, such as AD.

EQS-News: ENCAVIS AG acquires wind farm (17 megawatts) in Sommerland in Schleswig-Holstein from BayWa r.e., thereby increasing the generation capacity of its German wind farm portfolio to 257 megawatts

Retrieved on: 
Monday, September 25, 2023

ENCAVIS AG acquires wind farm (17 megawatts) in Sommerland in Schleswig-Holstein from BayWa r.e., thereby increasing the generation capacity of its German wind farm portfolio to 257 megawatts

Key Points: 
  • ENCAVIS AG acquires wind farm (17 megawatts) in Sommerland in Schleswig-Holstein from BayWa r.e., thereby increasing the generation capacity of its German wind farm portfolio to 257 megawatts
    The issuer is solely responsible for the content of this announcement.
  • ENCAVIS acquires wind farm (17 megawatts) in Sommerland in Schleswig-Holstein from BayWa r.e., thereby increasing the generation capacity of its German wind farm portfolio to 257 megawatts
    Hamburg, 20 September 2023 – Hamburg-based wind and solar park operator Encavis AG, listed on the MDAX of Deutsche Börse AG (Prime Standard; ISIN: DE0006095003; ticker symbol: ECV) acquires a 17-megawatt (MW) wind farm in Sommerland (Schleswig-Holstein) from BayWa r.e.
  • “This wind farm will increase our total wind power generation capacity in Germany to 257 megawatts,” says Mario Schirru, CIO/COO of Encavis AG, welcoming the acquisition in Sommerland in Northern Germany.
  • After acquiring the project rights two years ago, we were able to successfully complete the wind farm in Sommerland.

EQS-News: Nordex SE: Nordex Group receives orders for 180 MW from Germany

Retrieved on: 
Tuesday, September 5, 2023

The Nordex Group made a successful start to the third quarter of 2023 in the German market in July and August with orders totalling 181 MW.

Key Points: 
  • The Nordex Group made a successful start to the third quarter of 2023 in the German market in July and August with orders totalling 181 MW.
  • The Nordex Group supplies 32 turbines for various customers for projects in Lower Saxony, Brandenburg, Schleswig-Holstein and North Rhine-Westphalia, among others.
  • "We are delighted that our customers have placed the new orders," says Felipe Villalon Waldburg-Zeil, Director Sales Region Central at the Nordex Group.
  • "The largest wind farm in Germany is currently being built in Gevensleben for the Nordex Group and the Landwind-Group.

Medtronic receives CE Mark approval for Inceptiv™ spinal cord stimulator with closed-loop sensing to treat chronic pain

Retrieved on: 
Friday, August 25, 2023

DUBLIN, Aug. 25, 2023 /PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technology, has received CE (Conformité Européenne) Mark approval for its Inceptiv™ closed-loop rechargeable spinal cord stimulator (SCS). It is the first Medtronic SCS device to offer a closed-loop feature that senses each person's unique biological signals and adjusts stimulation moment to moment, as needed, to keep therapy in harmony with the motions of daily life. †

Key Points: 
  • DUBLIN, Aug. 25, 2023 /PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technology, has received CE (Conformité Européenne) Mark approval for its Inceptiv™ closed-loop rechargeable spinal cord stimulator (SCS).

  • Spinal cord stimulators deliver mild electrical impulses to the spinal cord, which can disrupt pain signals before they reach the brain.
  • This in turn may lead some patients to turn down their device's stimulation output, resulting in a suboptimal therapy experience.
  • "This approval marks the beginning of a new era of pain relief, using sensing technology to listen to the unique biological signals of each patient."

Kamux Corporation's Half Year Financial Report for January 1-June 30, 2023: Revenue increased and adjusted operating profit at previous year's level

Retrieved on: 
Friday, August 11, 2023

HÄMEENLINNA, Finland, Aug. 11, 2023 /PRNewswire/ -- Kamux Corporation's Half Year Financial Report for January 1–June 30, 2023: Revenue increased and adjusted operating profit at previous year's level

Key Points: 
  • Q2 adjusted operating profit was at the previous year's level at EUR 4.5 million, but the reported operating profit decreased due to one-off items at the Group level.
  • In addition, operating profit was negatively affected by increased costs resulting from the capacity increase in Sweden in 2022 and costs increasing faster than revenue in Finland.
  • The number of plug-in hybrids and EVs sold by Kamux increased by 62% compared to the second quarter of 2022.
  • In 2023, Kamux expects its adjusted operating profit to grow from the year 2022, when the adjusted operating profit was EUR 17.5 million.

EQS-News: Sustainable energy generation at Wacken Open Air: Sponsor GP JOULE relies on hydrogen fuel cells of SFC Energy

Retrieved on: 
Friday, August 4, 2023

Sustainable energy generation at Wacken Open Air: Sponsor GP JOULE relies on hydrogen fuel cells of SFC Energy

Key Points: 
  • Sustainable energy generation at Wacken Open Air: Sponsor GP JOULE relies on hydrogen fuel cells of SFC Energy
    The issuer is solely responsible for the content of this announcement.
  • Sustainable energy generation at Wacken Open Air: Sponsor GP JOULE relies on hydrogen fuel cells of SFC Energy
    Brunnthal/Munich, Germany, August 4, 2023 - Products of SFC Energy AG ( F3C: DE, ISIN: DE0007568578 ), a leading supplier of hydrogen and methanol fuel cells for stationary and mobile hybrid power solutions, is prominent in sustainable energy supply at Wacken Open Air 2023.
  • The festival sponsor GP JOULE supplies parts of the technology for the festival operation with electricity from green hydrogen as part of a sponsorship.
  • GP JOULE supplies the green hydrogen and our fuel cells generate sustainable electricity from it.

EQS-News: Traum-Ferienwohnungen reports a 14% surge in new home listings in first quarter of 2023

Retrieved on: 
Monday, July 3, 2023

Bremen, Germany, 03 July 2023: Traum-Ferienwohnungen, one of the leading online vacation rental platforms in Europe, announced a strong increase in new vacation home listings during the first quarter of 2023 in Germany.

Key Points: 
  • Bremen, Germany, 03 July 2023: Traum-Ferienwohnungen, one of the leading online vacation rental platforms in Europe, announced a strong increase in new vacation home listings during the first quarter of 2023 in Germany.
  • The company added a total of 4,236 new listings, a 14% rise from the 3,709 listings added during the same quarter last year.
  • Among the regions witnessing the growth, Schleswig-Holstein takes the lead with 32% of new home listings, followed by Niedersachsen and Mecklenburg-Vorpommern at 24% and 21 % respectively.
  • With their diverse attractions and beautiful natural landscapes, these regions have captured the interest of travellers across Germany.

EQS-News: PNE AG successful in onshore wind power tenders

Retrieved on: 
Tuesday, June 27, 2023

Cuxhaven, June 27, 2023 - The PNE Group was once again very successful in the latest round of tenders for onshore wind turbines issued by the Bundesnetzagentur.

Key Points: 
  • Cuxhaven, June 27, 2023 - The PNE Group was once again very successful in the latest round of tenders for onshore wind turbines issued by the Bundesnetzagentur.
  • The wind power projects in "Heidmoor" and "Bebensee" made it through the tender process, having already received their permits in the first quarter of this year.
  • In "Heidmoor" 6 wind turbines with a total rated output of 36 megawatts (MW) are to be built, in "Bebensee" 5 wind turbines with a total output of 33 MW.
  • In this way, we are further strengthening our position as an independent power producer (IPP)," says Markus Lesser, CEO of PNE AG.

Germany Power Rental Market Assessment Report 2023: A $358 Million Market by 2029 - Government's Focus on Clean Energy and Investments are Likely to Push Demand - ResearchAndMarkets.com

Retrieved on: 
Monday, May 29, 2023

The "Germany Power Rental Market - Strategic Assessment & Forecast 2023-2029" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Germany Power Rental Market - Strategic Assessment & Forecast 2023-2029" report has been added to ResearchAndMarkets.com's offering.
  • This was the first project in Germany to obtain a loan from the EIB under the new Invest EU program.
  • The key players in the Germany power rental market are United Rentals, Sunbelt, Aggreko, Atlas Copco, Caterpillar, Cummins, and Kohler power.
  • The top 4 prominent vendors, including United Rentals, Sunbelt, Aggreko, and Speedy, account for over 52% of the Germany power rental market share.